INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of FOREST LABORATORIES, INC. and Its Board of Directors In Connection With the Sale of the Company to Actavis plc

NEW YORK--(BUSINESS WIRE)--

Levi & Korsinsky commenced an investigation of the Board of Directors of Forest Laboratories, Inc. (“Forest” or “the Company”) FRX for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Actavis plc ACT.

Click here to learn more: http://zlk.9nl.com/forest-laboratories-frx, or call: 877-363-5972. There is no cost or obligation to you.

Under the terms of the transaction, Forest shareholders will receive $26.04 in cash and 0.3306 of an Actavis share for each share of Forest stock they own, representing a value of approximately $89.48 in cash. The investigation concerns whether the Forest Board breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Actavis is underpaying for Forest shares.

If you own Forest common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/forest-laboratories-frx.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.